Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Biomarkers for down syndrome prenatal diagnosis

A biomarker, region-based technology, applied in the field of biochemistry, can address issues such as increased risk of fetuses with Down syndrome

Inactive Publication Date: 2015-08-12
AGENCY FOR SCI TECH & RES +1
View PDF1 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, certain conditions, such as older maternal age and having another child with Down syndrome or a previous pregnancy, have been found to increase the risk of having a fetus with Down syndrome

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Biomarkers for down syndrome prenatal diagnosis
  • Biomarkers for down syndrome prenatal diagnosis
  • Biomarkers for down syndrome prenatal diagnosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0187] Example 1 - Discovery of DNA Methylation Biomarkers

[0188] Maternal plasma DNA from peripheral blood of pregnant women contains maternal DNA (mainly derived from white blood cells) and fetal DNA (derived from placental cells). Fetal DNA constitutes approximately 10% of all cell-free DNA in maternal plasma. Fetal and maternal DNA can be distinguished based on DNA methylation differences in specific genomic regions between fetal and maternal DNA. Differences in DNA methylation are also present in placental DNA of normal and diseased fetuses. In some genomic regions, DNA methylation was higher in diseased samples compared to normal samples, but in other regions DNA methylation was lower in diseased samples.

[0189] Reduced representational bisulfite sequencing (RRBS) was used to quantify genome-wide DNA methylation profiles in normal and trisomy 21 placenta samples. Two restriction enzymes (TaqαI and MspI, both from New England Biolabs) were used to digest genomic DN...

Embodiment 2

[0192] Example 2 - T21 fetal detection using methylation biomarkers

[0193] figure 1 A schematic is shown describing the following steps. Step 1: Removal of unmethylated DNA of selected biomarkers by methylation-sensitive restriction enzymes. In the case of experiments with fetal / maternal DNA mixtures, this step removes the maternal DNA background since the biomarker regions are mostly unmethylated. Methylation-sensitive 25 ng of genomic DNA in a 15 μL system containing 1x Buffer 4, 1x BSA, 9 units of BstUI, 10 units of HpaII, and 10 units of HhaI (New England Biolabs, USA) Restriction enzyme digestion. A mock digestion without restriction enzyme was set up as a control. Samples were incubated at 37°C for 2 hrs, then at 60°C for 2 hrs.

[0194] Step 2: Exonuclease I treatment is used to remove the 3' overhang of the digested DNA. 10 units of exonuclease I (New England Biolabs, USA) were added to the enzyme-digested samples and incubated at 37°C for 1 hr, then heat inact...

Embodiment 3

[0199] Example 3 - T21 fetal detection using methylation biomarkers.

[0200] 10 mL of peripheral blood from each individual was collected into EDTA tubes. Blood samples were centrifuged at 1,790 g for 10 min at 4°C. The supernatant was transferred to a new microcentrifuge tube and centrifuged at 16,100 g for 10 min at 4°C. The upper layer of cell-free plasma was then collected and stored at -80°C. DNA was extracted from 1.6 mL plasma from pregnant women using the QIAamp DNA Blood Mini Kit (QIAGEN GmbH, Germany) according to the manufacturer's instructions. DNA samples washed with 75 μL of DNase- and RNase-free water (Sigma) were stored at -80°C.

[0201] Step 1: Removal of unmethylated DNA for selected biomarkers by methylation-sensitive restriction enzymes. In the case of experiments with fetal / maternal DNA mixtures, this step removes the maternal DNA background since the biomarker regions are mostly unmethylated. Half of the genomic DNA extracted from maternal plasma w...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Disclosed is an isolated biomarker / biomarker region. Also disclosed are isolated biomarker / biomarker regions for detecting trisomy 21, methods of determining the likelihood of a foetus to suffer from a specific disease using the biomarker / biomarker region, a kit and a method of determining the methylation levels of a biomarker / biomarker region.

Description

[0001] Cross References to Related Applications [0002] This application claims the benefit of priority from Singapore Patent Application No. 201207172-6 filed on 26 September 2012, the entire contents of which are incorporated herein by reference for all purposes. technical field [0003] The present invention relates to biochemistry, in particular biomarkers / biomarker area. In particular, the invention relates to biomarkers / regions of biomarkers associated with Down syndrome and methods of using said biomarkers to determine the likelihood of a fetus having Down syndrome. Background of the invention [0004] Current methods used to screen for congenital disorders in fetuses include ultrasound such as nuchal translucency (NT) and other tests that detect biomarkers found in maternal serum. For example, in screening for Down syndrome, biomarkers measured include the amount of alpha-fetoprotein (AFP) and human chorionic gonadotropin produced by the fetus and placenta and whic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68G01N33/50
CPCC12Q2600/154C12Q1/6816C12Q1/6883C12Q1/6888C12Q2600/158C12Q2521/331
Inventor 丁春明金胜男李有国杨秀雄
Owner AGENCY FOR SCI TECH & RES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com